Catalog

Familial Hypercholesterolemia: Improving Detection to Accelerate Treatment

What You Will Learn

  • Key indicators to flag a potential diagnosis of HeFH and HoFH
  • When to make a referral to a specialist
  • How to utilize genetic testing and cascade screening
  • Guideline recommendations for universal screening in children
  • Treatment options, including use of novel therapies
  • Strategies for ongoing management of FH patient

Every Patient, Every Time: Recognizing Familial Hypercholesterolemia

This infographic highlights the importance of recognizing and screening for familial hypercholesterolemia.

Learn More >

 

Expert Analysis

Experts share their knowledge in written format

Homozygous Familial Hypercholesterolemia: Diagnosis and Emerging Therapies ➔

 

Resources

World Heart Federation presents “Ensuring Timely Screening for Homozygous Familial Hypercholesterolemia in the US.” This video presents an engaging panel discussion focused on the challenges and advancements in diagnosing and managing Homozygous Familial Hypercholesterolemia (HoFH). ➔
World Heart Federation’s 2024 publication, It is Time to Screen for Homozygous Familial Hypercholesterolemia in the United States reviews best practices in screening for HoFH worldwide and proposes a set of actionable measures that individual states, as well as other countries, can implement to reduce the burden of HoFH. In addition, our paper also outlines key research and policy gaps that need to be addressed to pave the way for universal newborn screening of HoFH in the United States. ➔

 

We are grateful to these distinguished faculty who contributed to this collection:

Faculty

Michael D. Shapiro, DO, FACC (Chair)

Charles German, MD, MS

Christie M. Ballantyne, MD, FACC

Pam Taub, MD, FACC 

Raul D. Santos MD, PhD, MSc

Salim S. Virani, MD, FACC

Sarah de Ferranti MD, MPH

Educational Grant Support Provided By: Regeneron | Page Launched: February 2022

Page Launched: September 2023

Android App Download IOS App Download Powered By